Concepedia

Author

Mark E. Jones

Keysight Technologies (United States)

Also Known As

M. E. Jones, M.E. Jones, Mark E Jones, Mark E. Jones

17

Publications

1.5K

Citations

14

H-Index

25

Concepts

All Affiliations

Keysight Technologies (United States)United States Military Academy
ME

About

Mark E. Jones is an author at Keysight Technologies (United States) specializing in clinical microbiology, antimicrobial resistance, and infection control.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

810

2

Health Sciences

6

6

640

3

Epidemiology

6

6

417

4

Microbiology

6

6

599

5

Public Health

1

1

134

Mark E. Jones

×

13

Publications

1.4K

Citations

13

H-Index

YearCitations

Surveillance for Antimicrobial Susceptibility among Clinical Isolates of <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii</i> from Hospitalized Patients in the United States, 1998 to 2001

James A. Karlowsky, Deborah C. Draghi, Mark E. Jones,

Antimicrobial Agents and Chemotherapy

2003

351

Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds

Pedro Martinez-Freijo, Ad C. Fluit, F.-J. Schmitz,

Journal of Antimicrobial Chemotherapy

1998

247

Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002

James A. Karlowsky, Mark E. Jones, Deborah C. Draghi,

Annals of Clinical Microbiology and Antimicrobials

2004

210

Trends in Antimicrobial Susceptibilities among <i>Enterobacteriaceae</i> Isolated from Hospitalized Patients in the United States from 1998 to 2001

James A. Karlowsky, Mark E. Jones, Clyde Thornsberry,

Antimicrobial Agents and Chemotherapy

2003

134

Factors Associated with Relative Rates of Antibiotic Resistance in <i>Pseudomonas aeruginosa</i> Isolates Tested in Clinical Laboratories in the United States from 1999 to 2002

Robert K. Flamm, Mellany K. Weaver, Clyde Thornsberry,

Antimicrobial Agents and Chemotherapy

2004

123

Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999

James A. Karlowsky, Mark E. Jones, Clyde Thornsberry,

International Journal of Antimicrobial Agents

2001

99

Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States

James A. Karlowsky, Laurie J. Kelly, Clyde Thornsberry,

International Journal of Antimicrobial Agents

2002

90

In Vitro Susceptibilities of Gram-Negative Bacteria Isolated from Hospitalized Patients in Four European Countries, Canada, and the United States in 2000-2001 to Expanded-Spectrum Cephalosporins and Comparator Antimicrobials: Implications for Therapy

Richard P. Wenzel, Daniel F. Sahm, Clyde Thornsberry,

Antimicrobial Agents and Chemotherapy

2003

58

Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmeningeal isolates of Streptococcus pneumoniae by clinical laboratories in the United States during 2002 and 2003

Ronald N. Master, Deborah C. Draghi, Mark E. Jones,

Annals of Clinical Microbiology and Antimicrobials

2004

41

Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy

Mark E. Jones, James A. Karlowsky, Deborah C. Draghi,

International Journal of Antimicrobial Agents

2004

23

Page 1